At a glance
ClinicalIndex Comparison RecordPhase 3Completed
Drug / intervention
Lung volume reduction surgeryprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
National Emphysema Treatment Trial (NETT)
National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Apr 14, 2016
In Brief
A Phase 3 clinical trial evaluating Lung volume reduction surgery for Emphysema and 3 related conditions. Completed.
Detailed Summary
To evaluate the long term efficacy, morbidity and mortality associated with medical therapy with lung volume reduction surgery (LVRS) as compared to medical therapy alone and to define patient selection criteria. The trial, conducted in conjunction with a patient registry, is supported by the NHLBI, the Centers for Medicare and Medicaid Services (CMS), and the Agency for Healthcare Research and Quality (AHRQ).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEmphysema, Lung Diseases, Lung Diseases, Obstructive, Chronic Obstructive Pulmonary Disease
Countries--
Collaborators--
Timeline
Phase 3CompletedFinished
1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartDec 1996
First PostedOct 1999
Primary CompletionDec 2005
TodayJul 2026
First PostedOct 28, 1999
Enrollment StartDec 1, 1996
Primary CompletionDec 1, 2005
TodayJul 2, 2026
Enrollment to primary: 9 yearsPosted 26.7 years ago
Interventions
Lung volume reduction surgeryprocedure